The Food and Drug Administration punted deciding how it might regulate CBD products, instead calling on elected officials to help set the rules.Federal regulators believe the cannabis-derived compound, also called cannabidiol, could pose a risk to people and pets that can not be addressed by existing protocols.
[
add
]
[
|
|
...
]